ConvaTec Group PLC (LSE:CTEC) - Share price - Overview

Stock Report

ConvaTec Group PLC CTEC

Last Price
GBX205.00

Day Change
1.10|0.54%

As of 19/07/2018
17:50:07 BST | GBX
Minimum 15 Minutes Delay.

Last Close203.90p
Day Range202.50 - 206.80
Mkt Cap4.00Bil
52-Wk Range181.98 - 316.70
Yield %0.00
ISINGB00BD3VFW73
Volume2,157,385
P/E2,594.94
P/S2.27
P/CF13.06

Share Price

Total Returns 18/07/2018

 Chg (%)  
More ...
ConvaTec Group PLC-5.43 
FTSE 100 TR GBP1.18
 
Financials
201520162017
More ...
Income Statement
Turnover1,650.401,688.301,764.60
Operating Profit230.40154.00247.80
Net Profit-93.80-203.40158.00
Reported EPS-0.05-0.150.08
Balance Sheet
Current Assets757.20765.20875.10
Non Current Assets3,034.202,743.102,925.80
Total Assets3,791.403,513.903,800.90
Current Liabilities285.60300.00323.10
Total Liabilities4,010.202,267.702,277.10
Total Equity-218.801,246.201,523.80
Cash Flow
Operating Cash Flow142.50113.90353.50
Net Change in Cash55.1015.704.70

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
17/05/2018DRick D. Anderson203.001,1160.00
17/05/2018DMr. Paul Moraviec227.0732,79174,459.00
03/05/2018PurchaseMr. Kasim Kutay224.086,000,00013,444,596.00
06/12/2017PurchaseDr. Rosalind Catherine Rivaz206.154,8219,938.00

Company Profile

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.

Sector

Medical Instruments & Supplies

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Next Event 05/10/2018

Annual General Meeting
Ratios
Comp
More ...
PER (E)34.83
Div Yld (E)1.99
PEG (E)2.65
ROCE6.40
Op Mrgn0.14
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Date08/09/1706/04/18
Ex-Div07/09/1705/04/18
Paid20/10/1717/05/18
Amnt1.063.10
Directors
More ...
Non-Executive DirectorMr. Jesper Ovesen
Non-Executive Director, ChairmanSir Christopher Charles Gent
Non-Executive DirectorRick D. Anderson
Non-Executive Director, Deputy ChairmanSteven John Holliday
Non-Executive DirectorDr. Rosalind Catherine Rivaz
Executive Director, Chief Executive OfficerMr. Paul Moraviec
Executive Director, Chief Financial OfficerFrank Schulkes
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.